Nutriband Inc. Advances in Opioid Safety with AVERSA(TM) Fentanyl Milestone
Nutriband Inc. (NASDAQ: NTRB) has recently completed commercial-scale manufacturing for AVERSA(TM) Fentanyl, a pivotal step toward FDA approval, in collaboration with Kindeva Drug Delivery. This development underscores the company’s commitment to redefining opioid safety amidst the ongoing crisis. AVERSA(TM) Fentanyl, protected by international patents, represents a breakthrough in abuse-deterrent technology, potentially addressing a critical gap […]